115 related articles for article (PubMed ID: 8431515)
1. Radioiodination of proteins using N-succinimidyl 4-hydroxy-3-iodobenzoate.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1993; 4(1):78-84. PubMed ID: 8431515
[TBL] [Abstract][Full Text] [Related]
2. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1997; 8(5):724-9. PubMed ID: 9327137
[TBL] [Abstract][Full Text] [Related]
3. Radioiodination of antibodies via N-succinimidyl 2,4-dimethoxy-3-(trialkylstannyl)benzoates.
Vaidyanathan G; Zalutsky MR
Bioconjug Chem; 1990; 1(6):387-93. PubMed ID: 2099187
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent bearing acylation agent.
Shankar S; Vaidyanathan G; Affleck DJ; Peixoto K; Bigner DD; Zalutsky MR
Nucl Med Biol; 2004 Oct; 31(7):909-19. PubMed ID: 15464393
[TBL] [Abstract][Full Text] [Related]
5. Protein radiohalogenation: observations on the design of N-succinimidyl ester acylation agents.
Vaidyanathan G; Zalutsky MR
Bioconjug Chem; 1990; 1(4):269-73. PubMed ID: 2096920
[TBL] [Abstract][Full Text] [Related]
6. N-succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylates: a new class of reagents for protein radioiodination.
Garg S; Garg PK; Zalutsky MR
Bioconjug Chem; 1991; 2(1):50-6. PubMed ID: 1878411
[TBL] [Abstract][Full Text] [Related]
7. Radioiodination of a monoclonal antibody using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
Garg S; Garg PK; Zhao XG; Friedman HS; Bigner DD; Zalutsky MR
Nucl Med Biol; 1993 Oct; 20(7):835-42. PubMed ID: 8241995
[TBL] [Abstract][Full Text] [Related]
8. Labeling proteins using aryl iodide acylation agents: influence of meta vs para substitution on in vivo stability.
Garg PK; Slade SK; Harrison CL; Zalutsky MR
Int J Rad Appl Instrum B; 1989; 16(7):669-73. PubMed ID: 2613522
[TBL] [Abstract][Full Text] [Related]
9. Enhanced binding and inertness to dehalogenation of alpha-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate.
Garg PK; Alston KL; Welsh PC; Zalutsky MR
Bioconjug Chem; 1996; 7(2):233-9. PubMed ID: 8983345
[TBL] [Abstract][Full Text] [Related]
10. N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: synthesis and potential utility for the radioiodination of monoclonal antibodies.
Garg PK; Garg S; Zalutsky MR
Nucl Med Biol; 1993 May; 20(4):379-87. PubMed ID: 8504279
[TBL] [Abstract][Full Text] [Related]
11. SIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies.
Vaidyanathan G; White BJ; Affleck DJ; Zhao XG; Welsh PC; McDougald D; Choi J; Zalutsky MR
Bioorg Med Chem; 2012 Dec; 20(24):6929-39. PubMed ID: 23159039
[TBL] [Abstract][Full Text] [Related]
12. Catabolism of radioiodinated murine monoclonal antibody F(ab')2 fragment labeled using N-succinimidyl 3-iodobenzoate and Iodogen methods.
Garg PK; Alston KL; Zalutsky MR
Bioconjug Chem; 1995; 6(4):493-501. PubMed ID: 7578370
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of iodovinyl antibody conjugates: comparison with a p-iodobenzoyl conjugate and direct radioiodination.
Hadley SW; Wilbur DS
Bioconjug Chem; 1990; 1(2):154-61. PubMed ID: 2095212
[TBL] [Abstract][Full Text] [Related]
14. Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate.
Zalutsky MR; Narula AS
Cancer Res; 1988 Mar; 48(6):1446-50. PubMed ID: 3345515
[TBL] [Abstract][Full Text] [Related]
15. A polar substituent-containing acylation agent for the radioiodination of internalizing monoclonal antibodies: N-succinimidyl 4-guanidinomethyl-3-[131I]iodobenzoate ([131I]SGMIB).
Vaidyanathan G; Affleck DJ; Li J; Welsh P; Zalutsky MR
Bioconjug Chem; 2001; 12(3):428-38. PubMed ID: 11353542
[TBL] [Abstract][Full Text] [Related]
16. Optimization of a convenient route to produce N-succinimidyl 4-radiodobenzoate for radioiodination of proteins.
Araujo EB; Santos JS; Colturato MT; Muramoto E; Silva CP
Appl Radiat Isot; 2003 Jun; 58(6):667-73. PubMed ID: 12798375
[TBL] [Abstract][Full Text] [Related]
17. Preparation of N-succinimidyl 3-[*I]iodobenzoate: an agent for the indirect radioiodination of proteins.
Vaidyanathan G; Zalutsky MR
Nat Protoc; 2006; 1(2):707-13. PubMed ID: 17406300
[TBL] [Abstract][Full Text] [Related]
18. Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody.
Foulon CF; Reist CJ; Bigner DD; Zalutsky MR
Cancer Res; 2000 Aug; 60(16):4453-60. PubMed ID: 10969792
[TBL] [Abstract][Full Text] [Related]
19. N-succinimidyl 3-[(131)I]iodo-4-phosphonomethylbenzoate ([(131)I]SIPMB), a negatively charged substituent-bearing acylation agent for the radioiodination of peptides and mAbs.
Shankar S; Vaidyanathan G; Affleck D; Welsh PC; Zalutsky MR
Bioconjug Chem; 2003; 14(2):331-41. PubMed ID: 12643743
[TBL] [Abstract][Full Text] [Related]
20. A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine.
Zalutsky MR; Narula AS
Int J Rad Appl Instrum A; 1987; 38(12):1051-5. PubMed ID: 2828275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
